Related Experiment Video
Updated: Jan 7, 2026

Author Spotlight: Accelerating Diagnostic Accuracy with Direct Identification of Gram-Negatives from Blood Culture Bottles
Published on: May 24, 2024
How to: the application and analysis of categorical agreement in antimicrobial susceptibility testing using European
John Turnidge1, Gunnar Kahlmeter2, Christian G Giske3
1School of Biological Sciences University of Adelaide, Adelaide, Australia.
Background:
In 2019, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) changed the definitions of susceptibility testing categories S, I, and R. The most notable change was the definition of the I category to susceptible-increased exposure. This change altered the assessment of categorical agreement when comparing susceptibility testing methods. Categorical agreement is defined as agreement of S, I, and R results between two sets of susceptibility test results, where one set is ideally, but not necessarily, generated with a reference method.
Objectives:
To outline principles for assessment of categorical agreement with the new SIR-classification system used by EUCAST.
Sources:
Assessment of presently used principles, followed by modification of the principles as required to adapt to the new SIR system.
Content:
The new system addresses logical inconsistencies that have been present since the revision of the EUCAST SIR system. Several errors involving the I-group have been upgraded from minor discrepancies to major discrepancies, given the new meaning of the I-group. A discrepancy by which a resistant isolate is classified as susceptible increased exposure must be regarded as a very major discrepancy.
Implications:
While assessment of categorical agreement is not routinely required in the development of susceptibility tests, there are still some situations where it can be helpful in assessing breakpoint or materials performance. The 'How To' provided here fills a gap created when EUCAST revised its SIR-classification system.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023